SCHEMBL2645141

SCHEMBL2645141

CC(C)(O)c1cc(-c2cnnc(-c3ccc(F)cc3F)n2)ccc1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.42
CYP1A2 P05177 1/20 0.42
GAA P10253 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.39
GABRG2 P18507 8/20 0.39
GABRB3 P28472 8/20 0.39
GABRA5 P31644 7/20 0.39
GABRA3 P34903 7/20 0.39
CNR2 P34972 1/20 0.39
PRKD3 O94806 2/20 0.35
MAP4K4 O95819 2/20 0.35
CSNK1D P48730 2/20 0.35
EGFR P00533 1/20 0.34
PRKD2 Q9BZL6 1/20 0.34
GABRA1 P14867 5/20 0.34
GABRA2 P47869 4/20 0.34
ALOX5AP P20292 3/20 0.33
FEN1 P39748 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2644388 0.86 MPL (0.45) ALDH1A1CYP1A2GAACYP2C9CYP2C19
SCHEMBL2645140 0.86 ALDH1A1 (0.41) ALDH1A1CYP1A2GAACYP2C9CYP2C19
SCHEMBL2644672 0.79 GABRG2 (0.43) ALDH1A1CYP1A2GAACYP2C9CYP2C19
SCHEMBL2644375 0.79 ALDH1A1 (0.40) ALDH1A1CYP1A2GAACYP2C9CYP2C19
SCHEMBL2645113 0.77 GABRG2 (0.46) ALDH1A1CYP1A2GAACYP2C9CYP2C19
SCHEMBL2645305 0.76 TRPA1 (0.43) ALDH1A1CYP1A2GAACYP2C9CYP2C19
SCHEMBL2645812 0.76 GABRG2 (0.47) ALDH1A1CYP1A2GAACYP2C9CYP2C19
SCHEMBL2644597 0.76 GABRG2 (0.46) ALDH1A1CYP1A2GAACYP2C9CYP2C19
SCHEMBL2644646 0.75 GABRG2 (0.43) ALDH1A1GAAGABRG2GABRB3GABRA5
SCHEMBL2645797 0.74 GABRG2 (0.49) ALDH1A1CYP1A2GAACYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040192692-A1 5-Phenyl[1,2,4]triazines as ligands for GABA-A alpha2/alpha3 receptors for treating anxiety or depression MERCK SHARP & DOHME, LTD. (GB) 2004-09-30 US claimed
US-6969716-B2 5-phenyl[1,2,4]triazines as ligands for GABA-A α2/α3 receptors for treating anxiety or depression MERCK SHARP & DOHME LTD. 2005-11-29 US disclosed
US-20040192692-A1 5-Phenyl[1,2,4]triazines as ligands for GABA-A alpha2/alpha3 receptors for treating anxiety or depression MERCK SHARP & DOHME, LTD. (GB) 2004-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040192692-A1 5-Phenyl[1,2,4]triazines as ligands for GABA-A alpha2/alpha3 receptors for treating anxiety or depression GABRA1, GABRA5, GABRA2 ALDH1A1 260/4885CYP1A2 413/4885GAA 3698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.